Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients ...

Compared with placebo, sodium zirconium cyclosilicate was associated with less need to lower or discontinue spironolactone.

USA: The REALIZE-K trial shows that a daily oral potassium binder can safely enable the use of mineralocorticoid receptor ...